These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21251937)

  • 1. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    Liu Y; Wang Z; Kwong SQ; Lui ELH; Friedman SL; Li FR; Lam RWC; Zhang GC; Zhang H; Ye T
    J Hepatol; 2011 Sep; 55(3):612-625. PubMed ID: 21251937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.
    Liu Y; Lui EL; Friedman SL; Li L; Ye T; Chen Y; Poon RT; Wo J; Kok TW; Fan ST
    Lab Invest; 2009 Feb; 89(2):209-21. PubMed ID: 19114984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.
    Woodhoo A; Iruarrizaga-Lejarreta M; Beraza N; García-Rodríguez JL; Embade N; Fernández-Ramos D; Martínez-López N; Gutiérrez-De Juan V; Arteta B; Caballeria J; Lu SC; Mato JM; Varela-Rey M; Martínez-Chantar ML
    Hepatology; 2012 Nov; 56(5):1870-82. PubMed ID: 22576182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis.
    Liu L; Wei J; Huo X; Fang S; Yao D; Gao J; Jiang H; Zhang X
    Mol Med Rep; 2012 Dec; 6(6):1231-8. PubMed ID: 22971838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
    Nakamura I; Zakharia K; Banini BA; Mikhail DS; Kim TH; Yang JD; Moser CD; Shaleh HM; Thornburgh SR; Walters I; Roberts LR
    PLoS One; 2014; 9(4):e92273. PubMed ID: 24710173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
    Kluwe J; Pradere JP; Gwak GY; Mencin A; De Minicis S; Osterreicher CH; Colmenero J; Bataller R; Schwabe RF
    Gastroenterology; 2010 Jan; 138(1):347-59. PubMed ID: 19782079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 11. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells.
    Park KC; Park JH; Jeon JY; Kim SY; Kim JM; Lim CY; Lee TH; Kim HK; Lee HG; Kim SM; Kwon HJ; Suh JS; Kim SW; Choi SH
    Br J Pharmacol; 2014 Nov; 171(21):4820-30. PubMed ID: 24467283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
    Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J; Bai K; Hong B; Zhang F; Zheng S
    Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
    Chilvery S; Bansod S; Saifi MA; Godugu C
    Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
    Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
    Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
    Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
    PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
    Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the effectiveness of tyrosine kinase inhibitor (TKI) in combination with a statin in reducing liver fibrosis.
    Mohammadalipour A; Hashemnia M; Goudarzi F; Ravan AP
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1183-1193. PubMed ID: 31396972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.